anti-VEGF

Innovent's anti-VEGF drug matches Eylea in phase 2 eye disease trial
Fierce Biotech
Tue, 03/19/24 - 11:21 am
Innovent
Regeneron
Bayer
anti-VEGF
neovascular age-related macular degeneration
IBI302
Eylea
New insight into a struggling AstraZeneca anti-VEGF drug could expand its use in cancer
Fierce Biotech
Fri, 05/17/19 - 07:20 pm
AstraZeneca
Avastin
anti-VEGF
cediranib
With anti-VEGF challenger in clinic, Kodiak files for IPO
BioCentury
Mon, 09/10/18 - 12:19 am
Kodiak Sciences
anti-VEGF
IPOs
Opthea touts data from wet-AMD trial
Drug Delivery Business News
Tue, 08/15/17 - 10:01 am
Opthea
clnical trials
wet-AMD
OPT-302
anti-VEGF